MEN-2A includes
## Core Concept
Multiple Endocrine Neoplasia Type 2A (MEN-2A) is a hereditary condition characterized by the occurrence of tumors in multiple endocrine glands. It is part of a spectrum of disorders known as Multiple Endocrine Neoplasias (MEN), which are inherited syndromes. MEN-2A specifically involves the development of medullary thyroid carcinoma, pheochromocytoma, and primary hyperparathyroidism.
## Why the Correct Answer is Right
The correct answer includes medullary thyroid carcinoma, pheochromocytoma, and primary hyperparathyroidism. MEN-2A is primarily associated with:
- **Medullary thyroid carcinoma (MTC)**: This is a tumor of the parafollicular cells (also known as C cells) of the thyroid gland, which produce calcitonin.
- **Pheochromocytoma**: This is a tumor of the adrenal glands that leads to excessive production of catecholamines, such as adrenaline and noradrenaline, causing high blood pressure.
- **Primary hyperparathyroidism**: This condition results from a tumor of the parathyroid glands, leading to an overproduction of parathyroid hormone (PTH), which regulates calcium levels in the blood.
## Why Each Wrong Option is Incorrect
- **Option A:** This option is incorrect because it does not accurately represent the combination of conditions associated with MEN-2A.
- **Option B:** This option is incorrect because, although it might include some components of MEN syndromes, it does not accurately represent MEN-2A.
- **Option C:** This option is incorrect for similar reasons; it does not accurately list the conditions associated with MEN-2A.
## Clinical Pearl / High-Yield Fact
A key clinical pearl for MEN-2A is that **screening for RET gene mutations** is crucial in families with a history of MEN-2A. Early identification of RET mutations can lead to prophylactic thyroidectomy in affected individuals, significantly reducing the risk of medullary thyroid carcinoma. This highlights the importance of genetic screening in managing hereditary endocrine disorders.
## Correct Answer: D. Medullary thyroid carcinoma, pheochromocytoma, and primary hyperparathyroidism.